Join us in-person in Milan, Italy for the CPhI Milan 2026. Learn more about our involvement in the event below.
Evotec At CPhI Milan 2026
Breaking the Batch Paradigm: Continuous Biomanufacturing at Commercial Scale
Date and Time: Thursday, October 8, 2026, 12:00 - 12:25 PM (CET)
Location: Hall 12 - 12F49, Next-Gen Bio track
As biologics portfolios expand and biosimilar competition increases, manufacturers are seeking new approaches to improve productivity, reduce cost of goods, and ensure supply continuity. Continuous biomanufacturing offers an agile alternative to traditional batch processing by enabling higher output, enhanced process consistency, and greater facility utilization within a smaller manufacturing footprint.
This presentation will explore how continuous biomanufacturing can be applied at commercial scale to support late-phase candidates, commercial biologics, and biosimilars. Integrated continuous processes can accelerate tech transfer, improve operational flexibility, and enable rapid capacity deployment while reducing capital investment requirements. They support scalable, resilient, and cost-effective commercial supply strategies.
The session will provide insights for biopharma leaders evaluating next-generation manufacturing models to meet growing market demand while enhancing competitiveness and long-term supply security.
Presented by Nick Hutchinson, Associate VP, Business Development at Just - Evotec Biologics
Beyond Polymorphs: Turning Solid-State Knowledge into Formulation Development Advantage
Date and Time: Thursday, October 8, 2026, 12:30 - 12:55 PM (CET)
Location: Supply & Formulation Excellence: Hall 2 - 2A132
Solid-state characterization is much more than identifying polymorphs. While crystal form is a critical determinant of drug performance, solid-state science provides a broader understanding of material properties that influence formulation design, manufacturability, stability, and product quality.
Through a series of formulation development scenarios, this presentation will illustrate how integrating solid-state characterization with formulation expertise enables informed decision-making throughout development. Attendees will discover how solid-state insights can guide material selection, anticipate development risks, and support the design of robust, stable, and high-quality drug products.
By demonstrating practical approaches to translating solid-state knowledge into formulation advantage, this session will show how scientific expertise can transform development challenges into successful formulation strategies.
Presented by Francesca Campi, Research Expert, Analytical Sciences 1
